During the past decade, Complejo Hospitalario Universitario A Coruna conducted 302 clinical trials. In the 10-year time frame, 302 clinical trials started and 127 clinical trials were completed, i.e. on average, 42.1% percent of trials that started reached the finish line to date. In the past 5 years, 166 clinical trials started and 85 clinical trials were completed. i.e. 51.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Complejo Hospitalario Universitario A Coruna" #1 sponsor was "Pfizer" with 38 trials, followed by "Spanish Breast Cancer Research Group" with 26 trials sponsored, "Janssen Research & Development, LLC" with 21 trials sponsored, "PETHEMA Foundation" with 19 trials sponsored and "Eli Lilly and Company" with 19 trials sponsored. Other sponsors include 323 different institutions and companies that sponsored additional 183 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Complejo Hospitalario Universitario A Coruna" #1 collaborator was "Hoffmann-La Roche" with 10 trials as a collaborator, "Pfizer" with 10 trials as a collaborator, "AstraZeneca" with 8 trials as a collaborator, "Bristol-Myers Squibb" with 8 trials as a collaborator and "Instituto de Salud Carlos III" with 5 trials as a collaborator. Other collaborators include 196 different institutions and companies that were collaborators in the rest 158 trials.

According to Clinical.Site data, the most researched conditions in "Complejo Hospitalario Universitario A Coruna" are "Breast Cancer" (27 trials), "Carcinoma, Non-Small-Cell Lung" (11 trials), "Metastatic Breast Cancer" (11 trials), "Rheumatoid Arthritis" (11 trials) and "Hemophilia A" (10 trials). Many other conditions were trialed in "Complejo Hospitalario Universitario A Coruna" in a lesser frequency.

Most popular intervention types in "Complejo Hospitalario Universitario A Coruna" are "Drug" (316 trials), "Biological" (41 trials), "Other" (33 trials), "Device" (23 trials) and "Procedure" (23 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (78 trials), "Carboplatin" (22 trials), "Pemetrexed" (11 trials), "Cyclophosphamide" (10 trials) and "Capecitabine" (9 trials). Other intervention names were less common.

The vast majority of trials in "Complejo Hospitalario Universitario A Coruna" are 388 trials for "All" genders, 36 trials for "Female" genders and 24 trials for "Male" genders.

Currently, there are 166 active trials in "Complejo Hospitalario Universitario A Coruna". 2 are not yet recruiting, 101 are recruiting, 62 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 216 completed trials in Complejo Hospitalario Universitario A Coruna, 2 suspended trials, and 40 terminated clinical trials to date.

Out of the total trials that were conducted in Complejo Hospitalario Universitario A Coruna, 21 "Phase 1" clinical trials were conducted, 127 "Phase 2" clinical trials and 157 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 42 trials, and there were also 25 trials that are defined as “Not Applicable".

Complejo Hospitalario Universitario A Coruna has several departments that took part in Clinical trials: "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Oncologia" - 27 trials, "Complejo Hospitalario Universitario de Santiago (CHUS) ; Servicio de Oncologia" - 24 trials, "Complexo Hospitalario de Vigo. Hospital Álvaro Cunqueiro; Servicio de Oncología" - 9 trials, "Hospital Alvaro Cunqueiro; Servicio de Neurologia" - 7 trials, "Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia" - 3 trials, "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Reumatologia" - 2 trials, "Complejo Hospitalario Universitario A Coruña (CHUAC); Servicio de Hematologia" - 2 trials